Alcohol and/or benzodiazepine use in injured road users.

Alcohol and/or benzodiazepine use in injured road users. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Alcohol and/or benzodiazepine use in injured road users. Abstract Text:

Blood samples of all patients (269) involved in a traffic accident and admitted to the Emergency Room of the University Hospital of Trauma Surgery in Innsbruck were analysed for alcohol and benzodiazepines. The large majority were drivers (55%) followed by passengers (19.7%), cyclists (12.6%) and pedestrians (12.3%). Alcohol was obviously the most commonly found drug in all groups (drivers: 36.9%; passengers: 15.1%; cyclists: 29.4%; pedestrians: 18.2%), with a mean BAC (blood alcohol concentration) high above the legal limit at the time of the study in Austria of 0.8 g/l (drivers: 1.49 +/- 54 g/l; passengers: 1.52 +/- 71 g/l; cyclists: 1.72 +/- 51 g/l; pedestrians: 1.67 +/- 25 g/l). The percentage of alcohol users was highest in drivers. Concerning BAC levels no significant differences were found between the groups.The most commonly detected benzodiazepine was diazepam. Benzodiazepine consumption (drivers: 8.1%; passengers: 5.7%; cyclists: 8.8%; pedestrians: 3%) as well as plasma levels (drivers: 68.7 +/- 62.6 microg/l; passengers: 61.0 +/- 69.3 microg/l; cyclists: 135.7 +/- 118.3 microg/l; pedestrians: 18 microg/l) were nearly equal in all groups.Concerning alcohol or benzodiazepine use, females showed lower frequencies of both alcohol and benzodiazepine positive blood samples. The frequency of alcohol use was higher in patients

Alcohol and/or benzodiazepine use in injured road users. Publishing Authors By Initials

For similar disorders of environmental origin: wounds and injuries research abstracts see: disorders of environmental origin: wounds and injuries research

PUBMED ID PMID:

MEDLINE DATE:

Alcohol and/or benzodiazepine use in injured road users. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Human psychopharmacology

VOLUME: 18

Page Numbers: 361-7

Journal Abbreviation: Hum Psychopharmacol

ISSN: 0885-6222

DAY: 6

MONTH: Jul

YEAR: 2003

Alcohol and/or benzodiazepine use in injured road users. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8702539

Alcohol and/or benzodiazepine use in injured road users. Keywords Mesh Terms:

KEYWORDS: Wounds and Injuries

MESH TERMS: statistics & numerical data

Chemical & Substance for Abstract: Alcohol and/or benzodiazepine use in injured road users. Information

Substance Name: Central Nervous System Agents

Registry Number: 0

Grant and Affiliation Information for Alcohol and/or benzodiazepine use in injured road users.

AFFILIATION: Innsbruck University Clinics, Department of Biological Psychiatry, Innsbruck, Austria. ilsemarie.kurzthaler@uibk.ac.at

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hum Psychopharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Alcohol and/or benzodiazepine use in injured road users Related Publications

• Alcohol and/or benzodiazepine use in injured road users.
• Alcohol and/or benzodiazepine use: different accidents--different impacts?
• An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.
• Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophrenia.
• Clock drawing, clock reading, clock setting, and judgment of clock faces in elderly people with dementia and depression.
• Compliance with antipsychotic treatment.
• Conflicting views on conflicts of interest in medicine.
• Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
• Interpretation of the Pandy test.
• Language lateralization in unmedicated patients during an acute episode of schizophrenia: a functional MRI study.
• Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients.
• Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity.
• New drugs for the treatment of schizophrenic patients.
• No evidence for an association between serum cholesterol and the course of depression and suicidality.
• Not Available
• Not Available
• Perspectives on treatment needs in schizophrenia.
• Schizophrenia today: do we know any more and can we treat it better than a decade ago?
• Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
• [Beta blockers in psychiatric diseases. Indications and problems]
• [Blood diseases.]
• [Blood diseases.]
• [Blood diseases.]
• [Cytostatic therapy.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Preleukemic states.]
• [The problems of older people]